Hudson Bay Capital Management’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-460,000	Closed	-$3.38M	–	698
2024 Q1	$3.38M	Buy	+460,000	New	+$3.38M	0.02%	318
2023 Q1	–	Sell	-51,754	Closed	-$522K	–	850
2022 Q4	$522K	Buy	+51,754	New	+$522K	0.01%	675